补充额外的对照临床试验来支持PWS的DCCR的NDA大概要多久呀,有知道的么

BRIEF-Soleno Therapeutics Provides Regulatory Update On DCCR For The Treatment Of Prader-Willi Syndrome

March 8 (Reuters) - Soleno Therapeutics Inc : * SOLENO THERAPEUTICS PROVIDES REGULATORY UPDATE O
BRIEF-Soleno Therapeutics Provides Regulatory Update On DCCR For The Treatment Of Prader-Willi Syndrome

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论